Keywords: داروهای دوپامینرژیک; Parkinson's disease; Impulse control disorders; Levodopa-induced dyskinesias; Behavioral addiction; Pathophysiology; Risk factors; Dopaminergic drugs; Basal ganglia; Neuroimaging; Neurochemistry; Genetics; Pharmacology;